Cargando…

Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

Detalles Bibliográficos
Autores principales:	Filippi, Massimo, Amato, Maria Pia, Centonze, Diego, Gallo, Paolo, Gasperini, Claudio, Inglese, Matilde, Patti, Francesco, Pozzilli, Carlo, Preziosa, Paolo, Trojano, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618484/ https://www.ncbi.nlm.nih.gov/pubmed/36138162 http://dx.doi.org/10.1007/s00415-022-11385-4

Ejemplares similares

Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
por: Filippi, Massimo, et al.
Publicado: (2022)

Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4
por: Centonze, Diego, et al.
Publicado: (2023)

Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus
por: Filippi, Massimo, et al.
Publicado: (2021)

Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
por: Centonze, Diego, et al.
Publicado: (2021)

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)
por: Comi, Giancarlo, et al.
Publicado: (2017)

First‐line therapies in late‐onset multiple sclerosis: An Italian registry study
por: Zanghì, Aurora, et al.
Publicado: (2021)

Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis
por: Amato, Maria Pia, et al.
Publicado: (2022)

Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2023)

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
por: Margoni, Monica, et al.
Publicado: (2021)

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies
por: Iaffaldano, Pietro, et al.
Publicado: (2021)

The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis
por: Albergoni, Matteo, et al.
Publicado: (2022)

COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
por: Preziosa, Paolo, et al.
Publicado: (2020)

Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression
por: Preziosa, Paolo, et al.
Publicado: (2022)

Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists
por: Marfia, Girolama Alessandra, et al.
Publicado: (2022)

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
por: Sormani, Maria Pia, et al.
Publicado: (2021)

Management of Osteoarthritis: Expert Opinion on NSAIDs
por: Magni, Alberto, et al.
Publicado: (2021)

An Internet- and Kinect-Based Multiple Sclerosis Fitness Intervention Training With Pilates Exercises: Development and Usability Study
por: Tacchino, Andrea, et al.
Publicado: (2023)

Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets
por: Gasperini, Claudio, et al.
Publicado: (2010)

Expert opinion on the use of cladribine tablets in clinical practice
por: Sørensen, Per Soelberg, et al.
Publicado: (2020)

Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register
por: D’Amico, Emanuele, et al.
Publicado: (2021)

Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
por: Mosconi, Paola, et al.
Publicado: (2023)

Mapping brain structure and function in professional fencers: A model to study training effects on central nervous system plasticity
por: Cordani, Claudio, et al.
Publicado: (2022)

Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients
por: Santoro, Silvia, et al.
Publicado: (2022)

Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets
por: Yamout, Bassem I, et al.
Publicado: (2022)

Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod
por: Gasperini, Claudio, et al.
Publicado: (2013)

The Italian multiple sclerosis register
por: Trojano, Maria, et al.
Publicado: (2018)

Job satisfaction among physicians and nurses involved in the management of multiple sclerosis: the role of happiness and meaning at work
por: Negri, Luca, et al.
Publicado: (2021)

Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study
por: Bastianello, Stefano, et al.
Publicado: (2011)

The present and the future of benzydamine: expert opinion paper
por: Bossi, Paolo, et al.
Publicado: (2023)

Experts Opinion
por: Goldberg, Ivan, et al.
Publicado: (2012)

Expert Opinion
Publicado: (1920)

Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis
por: Filippi, Massimo, et al.
Publicado: (2021)

Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice
por: Rieckmann, Peter, et al.
Publicado: (2021)

Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective
por: Filippi, Massimo, et al.
Publicado: (2022)

Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study
por: Patti, Francesco, et al.
Publicado: (2013)

Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis
por: Prosperini, Luca, et al.
Publicado: (2021)

Editorial: “Inside-Out” vs “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis
por: Luchicchi, Antonio, et al.
Publicado: (2021)

Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems
por: Bargagli, Anna Maria, et al.
Publicado: (2016)

More Expert Opinion
Publicado: (1920)

Experts’ Opinion for Improving Pertussis Vaccination Rates in Adolescents and Adults: A Call to Action
por: Gabutti, Giovanni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ot9lo9ro1mk3gp5f0kmj654sb8